NeoGenomics Inc. share price logo

NeoGenomics Inc.

NASDAQ: NEO

Small Cap

$14.11

-0.62

(-4.21%)

as on

NeoGenomics Inc. Stock Performance

as on July 11, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $13.96
    $14.70
    downward going graph

    1.06%

    Downside

    4.18%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $4.72
    $15.57
    downward going graph

    66.55%

    Downside

    10.35%

    Upside

    downward going graph

NeoGenomics Inc. share price movements today

Previous Close
$14.73
Open
$14.70
Volume
1.1M
Day's Low - High
$13.96 - $14.70
52 Week Low - High
$4.72 - $15.57

NeoGenomics Inc. Historical Returns

1 Month Return
+ 23.02 %
3 Month Return
+ 83.49 %
1 Year Return
+ 94.35 %
3 Year Return
-16.31 %
5 Year Return
-68.8 %

NeoGenomics Inc. Stock Fundamentals & Key Indicators

Check NeoGenomics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.9B

EPS (TTM)

0.18

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

1.31%

PE Ratio (TTM)

0

PEG Ratio

2.0871

EBITDA

4.3M

Revenue (TTM)

746.0M

Profit Margin

-13.30%

Return On Equity TTM

-11.56%

NeoGenomics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of NeoGenomics Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
NeoGenomics Inc. image
NeoGenomics Inc.
BUY$1.9B-68.8%NA-13.30%NA
Natera Inc. image
Natera Inc.
BUY$40.4B123.21%NA-9.05%NA
IDEXX Laboratories Inc. image
IDEXX Laboratories Inc.
BUY$44.1B-15.51%40.824.63%NA
Thermo Fisher Scientific Inc. image
Thermo Fisher Scientific Inc.
BUY$195.0B1.89%28.0115.15%0.35000000000000003%
Danaher Corporation image
Danaher Corporation
BUY$138.7B-28.26%37.0514.89%0.7100000000000001%

Stock Returns calculator for NeoGenomics Inc. Stock including INR - Dollar returns

The NeoGenomics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

NeoGenomics Inc. investment value today

Current value as on today

₹2,15,967

Returns

₹1,15,967

(+115.97%)

Returns from NeoGenomics Inc. Stock

₹94,353 (+94.35%)

Dollar Impact

₹21,615 (+21.61%)

Analyst Recommendation on NeoGenomics Inc. Stock

Based on 17 analysts

BUY

76.47%

Buy

23.53%

Hold

0.00%

Sell

Based on 17 analysts, 76.47% of analysts recommend a 'BUY' rating for NeoGenomics Inc.. Average target price of $15.11

NeoGenomics Inc. Share Price Target

Get share price movements and forecasts by analysts on NeoGenomics Inc..

What analysts predicted

6.62%UPSIDE

Target Price

$15.11

Current Price

$14.11

Analyzed by

17 Analysts

Target

$15.11

NeoGenomics Inc. target price $15.11, a slight upside of 6.62% compared to current price of $14.11. According to 17 analysts rating.

Indian Investors' Interest in NeoGenomics Inc. Stock

Search interest for NeoGenomics Inc. Stock has increased by 10% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:10% versus previous 30 day period

NeoGenomics Inc. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
155
156
164
167
172
168
181
187
190
186
Gross Profit
67
65
72
74
77
73
77
80
75
80
Operating Income
-18
-30
-21
-21
-18
-27
-47
-27
-11
-18
EBITDA
4
-7
0
1
3
-6
-27
-9
4
0
Interest Expense
1
1
1
1
1
1
0
0
0
0
Depreciation
18
18
18
17
18
17
17
16
16
16
Income Before Tax
-15
-27
-19
-17
-16
-25
-45
-26
-12
-17
Income Tax Expense
0
0
0
0
0
0
0
0
-2
0
Net Income
-14
-27
-18
-17
-15
-25
-45
-27
-9
-17
Net Profit Margin
-9.21%
-17.32%
-11.33%
-10.55%
-8.91%
-15.43%
-24.87%
-14.45%
-5.20%
-9.16%

NeoGenomics Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
244
240
276
408
444
484
509
591
660
727
Gross Profit
110
101
127
196
185
187
187
244
290
282
Operating Income
2
2
10
13
-13
-118
-157
-107
-92
-66
EBITDA
25
26
31
37
34
46
-82
-17
-1
-38
Interest Expense
9
5
6
3
7
8
7
6
6
3
Depreciation
-
22
21
30
35
53
69
72
72
67
Income Before Tax
-7
-2
3
3
-14
-15
-159
-97
-80
-110
Income Tax Expense
-1
-2
1
-4
-18
-6
-15
-9
-1
-2
Net Income
-6
0
2
8
4
-8
-144
-87
-78
-108
Net Profit Margin
-2.52%
-0.16%
0.95%
1.96%
0.94%
-1.72%
-28.30%
-14.87%
-11.92%
-14.85%

NeoGenomics Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-27
-18
-17
-15
-25
-45
-27
-9
-17
Operating Cash Flow
-25
13
9
9
-25
20
8
1
-8
Investing Cash Flow
14
7
-3
-5
3
-9
0
-6
-5
Financing Cash Flow
0
1
1
0
0
-202
0
0
0
Change in Cash
-10
23
6
5
-20
-191
9
-4
-13

NeoGenomics Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
0
2
8
4
-8
-144
-87
-78
-108
Operating Cash Flow
18
44
23
1
-26
-65
-1
7
5
Investing Cash Flow
-13
-139
-19
-159
-632
0
76
12
-12
Financing Cash Flow
-4
91
159
235
725
11
4
4
-200
Change in Cash
0
-3
163
77
66
-53
79
24
-207

Global Institutional Holdings in NeoGenomics Inc.

Funds
Holdings
Greenhouse Funds LLLP
6.99%
Deerfield Management Co
1.66%
The Goldman Sachs Group Inc
1.39%
BRAIDWELL LP
4.31%
Partner Fund Management LP
1.37%
See all

NeoGenomics Inc. News & Key Events

  • img

    Today's Timeline - 16 October

    Thu, 11:35 AM

    -

    NeoGenomics shares climbed over 8% this week, reflecting renewed investor interest amid long-term challenges.

    Thu, 01:24 PM

    -

    NeoGenomics shares rose 6.3% to $9.97, driven by positive investor expectations and upcoming clinical data presentations.

Insights on NeoGenomics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, NEO has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, NEO stock has moved up by 30.6%

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 52.97% of holdings in Mar 2026 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 47.03% of holdings in Mar 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Natera, Inc. Common Stock has given 483.4% return, outperforming this stock by 496.5%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -9.88M → -17.10M (in $), with an average decrease of 73.1% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 190.17M → 186.67M (in $), with an average decrease of 1.8% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, NEO stock has moved down by -15.7%

About NeoGenomics Inc.

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company offers molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. The company was founded in 2001 and is headquartered in Fort Myers, Florida.
OrganisationNeoGenomics Inc.
Headquarters9490 NeoGenomics Way, Fort Myers, FL, United States, 33912
IndustryDiagnostics & Research
CEOMr. Anthony P. Zook
E-voting on sharesClick here to vote

Key Management of NeoGenomics Inc.

Name

Title

Mr. Anthony P. Zook

CEO & Director

Mr. Gregory D. Aunan

Senior VP & Chief Accounting Officer

Ms. Kendra Sweeney

Vice President of Investor Relations & Communications

Mr. Clarence Cooper Esq.

Vice President of Compliance & Privacy

Mr. Kareem M. Saad

Head of Strategy, Business Development & Transformation

Mr. Warren Stone

President & COO

Ms. Elizabeth A. Floegel

Chief Digital & Information Officer

Ms. Alicia C. Olivo

Executive VP of Business Development, General Counsel & Corporate Secretary

Mr. Gary Passman

Chief People & Culture Officer

Mr. Abhishek Jain

Executive VP & CFO

FAQs

What is NeoGenomics Inc. share price today?

NeoGenomics Inc. share price today is $14.11 as on at the close of the market. NeoGenomics Inc. share today touched a day high of $14.70 and a low of $13.96.

What is the 52 week high and 52 week low for NeoGenomics Inc. share?

NeoGenomics Inc. share touched a 52 week high of $15.57 on and a 52 week low of $4.72 on . NeoGenomics Inc. stock price today i.e. is closed at $14.11,which is 9.38% down from its 52 week high and 198.94% up from its 52 week low.

What is NeoGenomics Inc.'s market capitalisation today?

NeoGenomics Inc. market capitalisation is $0.00T as on .

How to invest in NeoGenomics Inc. Stock (NEO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for NeoGenomics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in NeoGenomics Inc. Shares that will get you 0.1063 shares as per NeoGenomics Inc. share price of $14.11 per share as on July 11, 2026 at 8:46 am IST.

What is the minimum amount required to buy NeoGenomics Inc. Stock (NEO) from India?

Indian investors can start investing in NeoGenomics Inc. (NEO) shares with as little as ₹95.37 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹953.70 in NeoGenomics Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on NeoGenomics Inc. share’s latest price of $14.11 as on July 11, 2026 at 8:46 am IST, you will get 0.7087 shares of NeoGenomics Inc.. Learn more about fractional shares .

What are the returns that NeoGenomics Inc. has given to Indian investors in the last 5 years?

NeoGenomics Inc. stock has given -68.8% share price returns and 28.19% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?